Thyroid cancer is the most common cancer associated with acromegaly

Pituitary

Volumn 13, Issue 3, 2010, Pages 242-248

  Gullu, Bennur Esen ^a   Celik, Ozlem ^a   Gazioglu, Nurperi ^a   Kadioglu, Pinar ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Acromegaly; GH; IGF I; Malignancies; Thyroid cancer

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADULT; ARTICLE; BILE DUCT CARCINOMA; BREAST CANCER; CANCER CLASSIFICATION; CANCER RISK; CANCER SCREENING; COLON CANCER; COLONOSCOPY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; ECHOGRAPHY; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MAMMOGRAPHY; MULTIPLE ENDOCRINE NEOPLASIA; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; SEX DIFFERENCE; THYROID CANCER; UTERINE CERVIX CANCER;

ACROMEGALY; ADULT; BREAST NEOPLASMS; COLONIC NEOPLASMS; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA; SEX FACTORS; THYROID NEOPLASMS;

EID: 77955895409     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-010-0224-9     Document Type: Article

References (44)

1. S Melmed 2006 Acromegaly N Engl J Med 355 2558 2573 10.1056/NEJMra062453 1:CAS:528:DC%2BD28XhtlWqsbzK 17167139 (Pubitemid 44917504)
2. J Ayuk MC Sheppard 2008 Does acromegaly enhance mortality? Rev Endocr Metab Disord 9 33 39 10.1007/s11154-007-9067-8 18075787
3. SM Melmed 2001 Acromegaly and cancer: not a problem? J Clin Endocrinol Metab 86 2929 2934 10.1210/jc.86.7.2929 1:CAS:528:DC%2BD3MXlt1GjsrY%3D 11443145 (Pubitemid 32673443)
4. P Cohen DR Clemmons RG Rosenfeld 2000 Does the GH-IGF axis play a role in cancer pathogenesis? Growth Horm IGF Res 10 297 305 10.1054/ghir.2000.0171 1:CAS:528:DC%2BD3MXht1Whsrc%3D 11161960 (Pubitemid 32125100)
5. AG Renehan 2008 Acromegaly, growth hormone and cancer risk Best Pract Res Clin Endocrinol Metab 22 4 639 657 10.1016/j.beem.2008.08.011 1:CAS:528:DC%2BD1cXht12rtr7O 18971124
6. M Webb Susan C Felipe AH Wass John 2002 Oncological complications of excess GH in acromegaly Pituitary 5 21 25 10.1023/A:1022149300972 1:STN:280:DC%2BD3s7isVClug%3D%3D 12638722 (Pubitemid 36267050)
7. P Jenkins A Mukherjeet SM Shalet 2006 Does growth hormone cause cancer? Clin Endocrinol 64 121 10.1111/j.1365-2265.2005.02404.x
8. SM Orme RJ McNally RA Cartwright PE Belchetz 1998 Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group J Clin Endocrinol Metab 83 2730 2734 10.1210/jc.83.8.2730 1:CAS:528:DyaK1cXltlWms7k%3D 9709939 (Pubitemid 28493768)
9. PJ Jenkins 2006 Cancers associated with acromegaly Neuroendocrinology 83 218 223 10.1159/000095531 1:CAS:528:DC%2BD28XhtV2hu7vP 17047386 (Pubitemid 44578875)
10. S Loeper S Ezzat 2008 Acromegaly: re-thinking the cancer risk Rev Endocr Metab Disord 9 41 58 10.1007/s11154-007-9063-z 1:CAS:528:DC%2BD1cXhs1KqurY%3D 18157698
11. JD Nabarro 1987 Acromegaly Clin Endocrinol 26 481 512 10.1111/j.1365-2265.1987.tb00805.x 1:STN:280:DyaL1c%2Fgt1yrsg%3D%3D
12. J Barzilay GJ Heatley GW Cushing 1991 Benign and malignant tumors in patients with acromegaly Arch Intern Med 151 1629 1632 10.1001/archinte.151.8. 1629 1:STN:280:DyaK3Mzjs1yjug%3D%3D 1678593
13. S Melmed 1996 Unwanted effects of GH excess in the adult J Pediatr Endocrinol Metab 9 369 374 8887183
14. E Ron G Gridley Z Hrubec W Page S Arora JF Fraumeni 1991 Acromegaly and gastrointestinal cancer Cancer 68 1673 1677 10.1002/1097-0142(19911015)68: 8<1673::AID-CNCR2820680802>3.0.CO;2-0 1:STN:280:DyaK38%2FgsFantA%3D%3D 1913507
15. V Popovic S Damjanovic D Micic M Nesovic M Djurovic M Petakov S Obradovic S Zoric M Simic Z Penezic J Marinkovic 1998 Increased incidence of neoplasia in patients with pituitary adenomas. The Pituitary Study Group Clin Endocrinol (Oxf) 49 441 445 10.1046/j.1365-2265.1998.00536.x 1:STN:280: DyaK1M%2FptlKhsg%3D%3D (Pubitemid 28475335)
16. A Giustina A Barkan F Casanueva F Cavagnini L Frohman K Ho J Veldhuis J Wass K Von Werder S Melmed 2000 Criteria for cure of acromegaly: a consensus statement J Clin Endocrinol Metab 85 526 529 10.1210/jc.85.2.526 1:CAS:528:DC%2BD3cXhtlyhtLw%3D 10690849 (Pubitemid 32273628)
17. O Tiryakioglu P Kadioglu NU Caneroglu H Hatemi 2003 Age dependency of serum insulin-like growth factor (IGF-1) in healthy Turkish adolescents and adults Indian J Med Sci 57 543 548 1:STN:280:DC%2BD2c%2FgsVylug%3D%3D 14701946
18. P Mustacchi MB Shimkin 1957 Occurrence of cancer in acromegaly and in hypopituitarism Cancer 10 1 100 104 10.1002/1097-0142(195701/02)10:1<100:: AID-CNCR2820100113>3.0.CO;2-V 1:STN:280:DyaG2s%2FmtVWltw%3D%3D 13413804
19. L Klein G Parveen JS Gavaler DH Vanthiel 1982 Colonic polpys in patients with acromegaly Ann Intern Med 97 1 27 30 1:STN:280:DyaL383ivFWksw%3D%3D 7092003
20. JE Brunner CC Johnson S Zafar EL Peterson JF Brunner RC Mellinger 1990 Colon cancer and polyps in acromegaly: increased risk associated with family history of colon cancer Clin Endocrinol 32 65 71 10.1111/j.1365-2265.1990. tb03751.x 1:STN:280:DyaK3c3jsFCiug%3D%3D
21. Y Higuchi N Saeki T Iuchi Y Uchino I Tatsuno D Uchida, et al. 2000 Incidence of malignant tumors in patients with acromegaly Endocr J 47 supply 57 60 10.1507/endocrj.47.SupplMarch-S57
22. D Baris G Gridley E Ron E Weiderpass L Mellemkjaer A Ekbom JH Olsen JA Baron JF Fraumeni Jr 2002 Acromegaly and cancer risk: a cohort study in Sweden and Denmark Cancer Causes Control 13 395 400 10.1023/A:1015713732717 1:STN:280:DC%2BD38zpslCgsg%3D%3D 12146843 (Pubitemid 34666594)
23. A Colao D Ferone P Marzullo G Lombardi 2004 Systemic complications of acromegaly: epidemiology, pathogenesis, and management Endocr Rev 25 102 150 10.1210/er.2002-0022 1:CAS:528:DC%2BD2cXhvFOmt7w%3D 14769829 (Pubitemid 38269977)
24. J Tornell L Rymo OG Isaksoon 1991 Induction of mammary adenocarcinomas in metallothionein promoter- human growth hormone transgenic mice Int J Cancer 49 114 117 10.1002/ijc.2910490121 1:STN:280:DyaK3MzktVCnsA%3D%3D 1874564
25. KK Kaulsay T Zhu W Bennett K Lee LobieE PE 2001 The effects of autocrine human growth hormone (hGH) on human mammary carcinoma cell behaviour are mediated via the hGH receptor Endocrinology 142 767 777 10.1210/en.142.2.767 1:CAS:528:DC%2BD3MXhtFSrt7w%3D 11159849 (Pubitemid 32222426)
26. T Zhu EL Goh R Graichen L Ling PE Lobie 2001 Signal transduction via the growth hormone receptor Cell Signal 13 9 599 616 10.1016/S0898-6568(01)00186-3 1:CAS:528:DC%2BD3MXlslGntL0%3D 11495718 (Pubitemid 32734097)
27. S Melmed 2009 Acromegaly pathogenesis and treatment J Clin Invest 119 3189 3202 10.1172/JCI39375 1:CAS:528:DC%2BD1MXhtlOitrjO 19884662
28. R Baserga 2000 The contradictions of the insulin-like growth factor 1 receptor Oncogene 19 5574 5581 10.1038/sj.onc.1203854 1:CAS:528: DC%2BD3cXosl2ntbY%3D 11114737
29. C Fidaner SY Eser DM Parkin 2001 Incidence in Izmir in 1993-1994: first results from Izmir cancer registry Eur J Cancer 37 83 92 10.1016/S0959-8049(00) 00355-5 1:STN:280:DC%2BD3M7kvVaitA%3D%3D 11165134 (Pubitemid 32119364)
30. P Tita MR Ambrosio C Scollo A Carta P Gangemi M Bondanelli R Vigneri EC Uberti V Pezzino 2005 High prevalence of differentiated thyroid carcinoma in acromegaly Clin Endocrinol 63 161 167 10.1111/j.1365-2265.2005.02316.x (Pubitemid 41097984)
31. C Balkany GW Cushing 1995 An association between acromegaly and thyroid carcinoma Thyroid 5 47 50 10.1089/thy.1995.5.47 1:STN:280:DyaK2MzgslSqsQ%3D%3D 7787433
32. S Franceschi S Preston Martin L DalMaso E Negri C LaVecchia WJ Mack A McTiernan L Kolonel SD Mark K Mabuchi F Jin G Wingren R Galanti A Hallquist E Glattre E Lund F Levi D Linos E Ron 1999 A pooled analysis of case control studies of thyroid cancer. Benign thyroid diseases Cancer Causes Control 10 583 595 10.1023/A:1008907227706 1:STN:280:DC%2BD3c%2FotlWitQ%3D%3D 10616827
33. G From A Mellemgaard N Knudsen T Jorgensen H Perrild 2000 Review of thyroid cancer cases among patients with previous benign thyroid disorders Thyroid 10 697 700 10.1089/10507250050137789 1:STN:280:DC%2BD3cvmt1altg%3D%3D 11014315
34. M Gasperi E Martino L Manetti M Arosio S Porretti G Faglia S Mariotti AM Colao G Lombardi R Baldelli F Camanni A Liuzzi 2002 Acromegaly Study Group of the Italian Society of Endocrinology. Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study J Endocrinol Invest 25 240 245 1:STN:280:DC%2BD383gtl2isQ%3D%3D 11936466
35. M Kurimoto I Fukuda N Hizuka K Tkano 2008 The prevalance of benign and malign tumors in patients with Acromegaly at a single institute Endocr J 55 67 71 10.1507/endocrj.K07E-010 18202526 (Pubitemid 351520181)
36. BD Li MJ Khosravi HJ Berkel A Diamandi MA Dayton M Smith H Yu 2001 Free insulin-like growth factor-I and breast cancer risk Int J Cancer 91 736 739 10.1002/1097-0215(200002)9999:9999<::AID-IJC1111>3.0.CO;2-# 1:CAS:528:DC%2BD3MXht1ygtL4%3D 11267989 (Pubitemid 32115273)
37. C Laban SA Bustin PJ Jenkins 2003 The GH-IGF-I axis and breast cancer Trends Endocrinol Metab 14 28 34 10.1016/S1043-2760(02)00003-6 1:CAS:528:DC%2BD38XptlWnur8%3D 12475609 (Pubitemid 36733929)
38. SE Hankinson WC Willett GA Colditz DJ Hunter DS Michaud B Deroo B Rosner FE Speizer M Pollak 1998 Circulating concentrations of insulin-like growth factor-I and risk of breast cancer Lancet 351 1393 1396 10.1016/S0140-6736(97) 10384-1 1:STN:280:DyaK1c3lsVansw%3D%3D 9593409 (Pubitemid 28209997)
39. AG Renehan P Bhaskar JE Painter ST O'Dwyer N Haboubi J Varma SG Ball SM Shalet 2000 The prevalence and characteristics of colorectal neoplasia in acromegaly J Clin Endocrinol Metab 85 3417 3424 10.1210/jc.85.9.3417 1:CAS:528:DC%2BD3cXmsVKqtrg%3D 10999843
40. PJ Jenkins PD Fairclough T Richards DG Lowe J Monson A Grossman JA Wass M Besser 1997 Acromegaly, colonic polyps and carcinoma Clin Endocrinol (Oxf) 47 17 22 10.1046/j.1365-2265.1997.1911029.x 1:STN:280:DyaK2svksl2htA%3D%3D
41. CS Mantzoros A Tzonou LB Signorello M Stampfer D Trichopoulos HO Adami 1997 Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia Br J Cancer 76 1115 1118 1:STN:280:DyaK1c%2FjtVCgug%3D%3D 9365156
42. A Wolk CS Mantzoros SO Andersson R Bergstrom LB Signorello P Lagiou HO Adami D Trichopoulos 1998 Insulin-like growth factor 1 and prostate cancer risk: a population based, case control study J Natl Cancer Inst 90 911 915 10.1093/jnci/90.12.911 1:CAS:528:DyaK1cXktFOqsLc%3D 9637140
43. SM Harman EJ Metter MR Blackman PK Landis HB Carter 2000 Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer J Clin Endocrinol Metab 85 4258 4265 10.1210/jc.85.11.4258 1:CAS:528: DC%2BD3cXotlWmsrs%3D 11095464 (Pubitemid 32055383)
44. JM Chan MJ Stampfer E Giovanucci PH Gann J Ma P Wilkinson CH Hennekens M Pollak 1998 Plasma insulin-like growth factor-1 and prostate cancer risk: a prospective study Science 279 563 566 10.1126/science.279.5350.563 1:CAS:528:DyaK1cXotVOqsg%3D%3D 9438850 (Pubitemid 28067285)